BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 223 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2019. The put-call ratio across all filers is 0.36 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $23,155,000 | +96.3% | 296,858 | +47.2% | 0.35% | +49.4% |
Q1 2020 | $11,797,000 | +265.8% | 201,734 | +401.2% | 0.24% | +446.5% |
Q4 2019 | $3,225,000 | -76.2% | 40,252 | -76.3% | 0.04% | -76.0% |
Q1 2019 | $13,569,000 | +78.5% | 169,505 | +41.5% | 0.18% | +163.2% |
Q2 2018 | $7,602,000 | +11.8% | 119,758 | +61.5% | 0.07% | +21.4% |
Q1 2018 | $6,800,000 | +27.9% | 74,156 | +5.2% | 0.06% | +33.3% |
Q4 2017 | $5,316,000 | -23.7% | 70,491 | -29.5% | 0.04% | -19.2% |
Q3 2017 | $6,967,000 | +191.6% | 100,000 | +67.4% | 0.05% | +173.7% |
Q1 2017 | $2,389,000 | -14.8% | 59,746 | -40.3% | 0.02% | -17.4% |
Q4 2016 | $2,805,000 | -24.6% | 100,000 | -45.6% | 0.02% | -34.3% |
Q2 2016 | $3,721,000 | +124.4% | 183,740 | +100.1% | 0.04% | +133.3% |
Q1 2016 | $1,658,000 | -15.3% | 91,837 | +23.6% | 0.02% | -28.6% |
Q4 2015 | $1,957,000 | +9.3% | 74,281 | -11.5% | 0.02% | 0.0% |
Q3 2015 | $1,791,000 | -55.6% | 83,914 | -45.0% | 0.02% | -8.7% |
Q2 2015 | $4,038,000 | – | 152,470 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 423,012 | $41,129,000 | 7.43% |
Eagle Health Investments LP | 133,163 | $12,947,000 | 5.08% |
DAFNA Capital Management LLC | 207,911 | $20,215,000 | 4.80% |
Casdin Capital, LLC | 1,550,000 | $150,707,000 | 4.49% |
SIB LLC | 65,151 | $6,335,000 | 3.72% |
CADIAN CAPITAL MANAGEMENT, LP | 913,702 | $88,839,000 | 3.29% |
Integral Health Asset Management, LLC | 117,500 | $11,425,000 | 3.26% |
Rock Springs Capital Management LP | 746,732 | $72,605,000 | 1.58% |
Avidity Partners Management LP | 546,000 | $53,088,000 | 1.47% |
Zebra Capital Management LLC | 12,698 | $1,235,000 | 1.36% |